The global anti-obesity drug market reflects this success, growing from $3.2 billion in 2024 to an estimated $120 billion by 2034 (a staggering 43.7% compound annual growth rate!)
Your provider will decide after reviewing your information
They are approved for type 2 diabetes management and obesity treatment in patients meeting specific BMI criteria, but their use for lipedema represents off-label prescribing with limited clinical evidence
Halukov LU, Valentoviov K, Huttov J, Mistrk I, Tams L (2009) Effect of abiotic stresses on glutathione peroxidase and glutathione S-transferase activity in barley root tips
GersteinHC,SattarN,RosenstockJetal.AMPLITUDE-O Trial Investigators
I have had many days recently with 100% TIR, which has been very rewarding (Celebrate the wins!)